STOP AF First Post-Approval Study

Conditions: Paroxysmal Atrial Fibrillation

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Enrollment: 200

Sponsor: Medtronic Cardiac Ablation Solutions

Location: Alaska Heart Institute Anchorage Alaska

Summary

The STOP AF First PAS is a prospective, global, multi-center, observational trial.

Eligibility Criteria

Inclusion Criteria: * Subject has been diagnosed with symptomatic paroxysmal AF * Subject is ≥ 18 years of age or minimum age as required by local regulations * Planned pulmonary vein isolation (PVI) procedure using the commercially available Arctic Front™ cardiac cryoablation catheter System. * Willing to comply with study requirements and give informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this clinical study) or authorization per institution and geographical requirements Exclusion Criteria: History of AF treatment with a class I or III antiarrhythmic drug, including sotalol, with the intention to prevent an AF recurrence1 . Subjects under the following conditions may be included in the study: 1. Temporary treatment with a class I or III AAD (treatment at a therapeutic dose for a period of \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05227053). StuddyBuddy aggregates publicly available trial information.